Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 760 | |||||
| (NASDAQ: AXSM) | Delayed: 162.33 +0.87 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $161.46 | 52 Week High | $15.74 | |||
| Open | $159.80 | 52 Week Low | $5.37 | |||
| Day High | $163.01 | P/E | N/A | |||
| Day Low | $158.41 | EPS | $0.00 | |||
| Volume | 386,982 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 3.34 +0.21 (6.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.13 | 52 Week High | $4.66 | |||
| Open | $3.05 | 52 Week Low | $2.01 | |||
| Day High | $3.47 | P/E | N/A | |||
| Day Low | $3.02 | EPS | $0.00 | |||
| Volume | 706,837 | |||||
